Series E Financing Reflects Sustained Investor Confidence in CeQur's Commercial Trajectory, Clinical Results, and Growing Demand for a Simpler Approach to Mealtime Insulin. Horw, Switzerland – June 9, 2026 – CeQur®, the company dedicated to simplifying mealtime insulin delivery for people living with diabetes, today announced the close of a [...]
Extended 7-Day Wear and 1-Unit Dosing Clearances, and Two ADA Posters Signal a New Standard for Mealtime Insulin Management. HORW, Switzerland, June 4, 2026 /PRNewswire/ – CeQur®, the company dedicated to simplifying mealtime insulin delivery for people living with diabetes, today announced two recent FDA clearances for CeQur Simplicity™: extended [...]
Patrick McBrayer Stepping Down Following Transformative Tenure That Positioned Company for Next Phase of Growth WESTBOROUGH, Massachusetts – May 11, 2026 – Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced Jamal [...]
Financing supported by DC Global Ventures, Lumination Capital, existing investors and a new strategic investor LAUSANNE, Switzerland & PALO ALTO, Calif.--(BUSINESS WIRE)--Polares Medical SA (“Polares”), a clinical-stage structural heart company developing the MRace Posterior Leaflet Replacement (PLR) system for mitral regurgitation (MR), today announced the closing of a $50 [...]
6x Higher Rate of Post-Traumatic Osteoarthritis (PTOA) for ACL Reconstruction Compared to BEAR Implant Observed in BEAR I and II Studies WESTBOROUGH, Massachusetts – January 14, 2026 – Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears, today announced that the U.S. Food and [...]
BOSTON, Jan. 8, 2026 /PRNewswire/ – IntelyCare, a leading technology-enabled healthcare staffing platform, today announced the acquisition of CareRev, the on-demand workforce platform purpose-built for acute care. The acquisition brings together two of the industry's most experienced operators in healthcare workforce management, creating one of the most comprehensive clinical labor [...]
Dr Peter Hackel to become CFO of the Medartis Group and to join its Executive Management Board (EMB) on 1 January 2026 Dr Dirk Kirsten, who served as CFO since 2021, will be concluding his service after a thorough transition Peter Hackel has an excellent track record in financial [...]
Minneapolis, Minnesota, October 29, 2025 – VentureMed Group, Inc., a leading medical device company specializing in vessel preparation and access management technologies for the treatment of peripheral arterial disease (PAD) and arteriovenous fistulas and grafts (AVF, AVG), today announced the closing of a $28 million Series C financing round [...]
Acquisition to expand the neuromodulation offerings for people living with chronic pain. MARLBOROUGH, Mass., Oct. 17, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on developing and commercializing innovative [...]
Basel, 17 July 2025: Following FDA approval of the KeriMedical TOUCH prosthesis on 10 July, the Medartis Group has decided to acquire the remaining 53% of the privately held company in accordance with the existing agreement. The transaction values the remaining shares at CHF 99 million in cash, with [...]